Zai Lab Limited is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for oncology, autoimmune, infectious, and neurological diseases. Headquarte... Zai Lab Limited is a biopharmaceutical company that focuses on the development and commercialization of innovative therapies for oncology, autoimmune, infectious, and neurological diseases. Headquartered in Shanghai, China, Zai Lab aims to address significant unmet medical needs, emphasizing ground-breaking treatments with a potential to transform patient outcomes. The company's primary function is to enhance the availability of critical pharmaceuticals in both the Chinese and global markets, often operating through strategic partnerships and licensing agreements with leading global biotech entities. Notably, Zai Lab Limited has made significant strides in the oncology sector, bringing forth therapies that target various types of cancer. Its mission extends beyond product development, as the firm is also involved in conducting clinical trials and obtaining regulatory approvals efficiently. In the financial market, Zai Lab Limited is regarded as a dynamic player within the pharma and biotech industries, reflecting the increasing demand for advanced therapeutics in emerging markets and contributing to both medical innovation and economic growth.Show lessShow more

Disclosures ESG Data Financial Data

Income Statement Balance Sheet Group Entities

Data not available

Group Entities data not yet covered for Zai Lab

We have not yet reviewed Zai Lab's disclosures for Group Entities data.

If this data is relevant to your work, you can submit a data coverage request and our team will investigate the company's disclosures and capture the data if available.

Would you like us to review Zai Lab's data?

Start your 30-day free trial to request a data review for Zai Lab.

Start Free Trial

Legal Center Contact Us